Stride

Compliance Team
Angels Den

Dear User,

You may have heard about the new General Data Protection Regulation (“GDPR”), that comes into effect May 25, 2018.

We would like to ensure you that your personal data is safe with us. Please read the details regarding the processing of your personal data and if you agree with the processing as described below, please click the ‘I agree’ button.

Please be informed that you can withdraw this consent at any time.

1) What data are we talking about?

We are disclosing details regarding the processing of personal data that is collected within our calls and in connection with your use of Angels Den’s platform, Websites and other functionalities of Angels Den, including those saved in cookies files.

2) Who will be the controller of your data?

Angels Den Funding Limited (hereinafter referred to as AD) will be the controller of your data (Angels Den means all entities from the Angels Den capital group, which includes Angels Den Funding Limited with its registered office in London and all entities related to it and dependent on it) and only our Trusted Partners.

3) Why do we want to process your data?

We process this data for the purposes described in our Privacy Policy, including:
- compliance with any legal requirements and obligations,
- ensuring that content from our Website is presented in the most effective manner for you,
- marketing purposes,
- providing you with our services (including the completion and support of immediate activity required to provide you with information and deliver products and/or services that you request and to deliver any contracts entered into with you), or
- as otherwise explained in this privacy policy or by any communication by us.
Where you have explicitly consented to be contacted for such purposes, we use your personal data to provide information on our new and existing products and services.

4) To whom can we transfer data?

In accordance with applicable law, we may transfer your data to entities processing it at our request, e.g. marketing agencies, subcontractors of our services and entities authorized to obtain data under applicable law, e.g. courts or law enforcement agencies - of course only if they submit a request based on an applicable legal basis. Furthermore, we will transfer your data to Trusted Partners outside the European Union – to the USA – under the EU-U.S. Privacy Shield Framework.

5) What are your rights to your data?

You have the right to request access to, correct, delete your personal data. You can also withdraw consent to processing of personal data, raise objections and use other rights granted under GDPR (i.e. right to data portability).

6) Use of cookies

We use cookies to give you the best experience on our Website. This means that we have placed cookies on your device. If you continue without changing your cookie settings, we assume that you consent to our use of cookies on this device. You can change your cookie settings at any time but if you do, you may lose some functionality on our Website. More information can be found in our Privacy Policy.

In connection with the above, I agree to the processing of my personal data by Angels Den and its Trusted Partners. I confirm that I understand that my personal data is being collected as part of my phone calls, use of AD’s online platform, Websites, and other functionalities of AD, including the data saved in cookie files. I also consent to profiling in order to allow Angels Den and its Trusted Partners the provision of better services (including for analytical purposes). Your data will only be processed on a valid lawful basis in accordance with applicable data protection laws. The processing of your personal data for marketing purposes (including statistical analysis) by AD is based on the firm's legitimate interest. The processing for marketing purposes by our Trusted Partners is only possible if we receive your freely given consent. We will also process your personal data to fulfil our contractual obligations to you as contained in AD’s Terms and Conditions of the use of our Website and services. Therefore, this data will be processed on another lawful basis – ‘contract’. We will also process your data to comply with our legal obligations for our Service (such as anti money laundering and know your customer requirements), which is also a valid lawful basis in accordance with applicable data protection laws.

Expressing this consent is voluntary and you can withdraw at any time.

If you have any doubts or questions about the use of your personal data, please do not hesitate to contact me via email. I’m happy to assist.

Compliance Team
Angels Den
cl@angelsden.com

I Agree

Not Now

STRIDE

Stride is on mission to set the new standard in optimal health. Using the power of a personaslied, diagnostics-led preventative health membership, we're making it easy to make health proactive.

Minimum Target

£ 900,000

Minimum investment amount

£ 5,000

Maximum Target

£ 1,500,000

Maximum investment amount

£ 250,000

Investment Opportunity

Stride is the UK’s first full-stack preventative health membership. Founded by Olympic medallist Andrew Steele and molecular geneticist Dr. Thomas Haizel, Stride integrates advanced diagnostics, telehealth coaching, supplements, and AI-driven insights into one seamless platform. Built on proprietary lab infrastructure and bioinformatics (SMAI), Stride empowers users to track, understand, and optimise their biology, transforming healthcare from reactive “sick care” to proactive, data-driven wellbeing

THE IDEA

Products & Services

Stride combines DNA, microbiome, blood, biological age, and oral health testing with human telehealth support, liposomal supplements, and a personal health OS. Its hero product, StrideOne, bundles recurring tests, AI summaries, and clinician-led optimisation into a single annual membership. The platform also includes a testing marketplace and proprietary SMAI engine, interpreting multi-omic data for precision interventions. Members receive digital insights, human coaching, and tailored supplements that evolve with their biomarkers.

Problem Solved

3 out of 4 deaths worldwide are attributed to 'chronic disease'. While this sounds alarming, it also presents an opportunity - chronic diseases are those we can actually do something to prevent. Traditional “sick care” systems are reactive, fragmented, and fail to prevent chronic disease. Consumers face scattered testing options, unvalidated supplements, and no clear roadmap for improvement. Stride solves this by unifying diagnostics, coaching, and interventions into one ecosystem — giving users clear visibility into their biology and evidence-based next steps. By turning biomarker tracking into a habit, Stride helps people move from simply “not ill” to truly optimal health.

Revenue Model

Stride is primarily a consumer DTC brand, with some smaller revenue lines in B2B. It generates revenue through four main streams:
Memberships (£499–£999/year) – the flagship StrideOne subscription combining testing, supplements, and coaching.
Testing marketplace (£149–£349) – DNA, blood, and microbiome tests that convert users into members.
Precision supplements (£79/month) – bespoke liposomal formulations improving biomarker outcomes.
In-house lab operations improve margins and LTV, while human coaching drives repeat engagement.
Practitioner and clinic partnerships - Indiviudal health practitoners and clinic groups use Stride as their diagnostics provider